©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 14, 2014; 20(42): 15499-15517
Published online Nov 14, 2014. doi: 10.3748/wjg.v20.i42.15499
Published online Nov 14, 2014. doi: 10.3748/wjg.v20.i42.15499
Table 3 Characterization of cirrhotic cardiomyopathy
| Definition |
| A cardiac dysfunction in patients with cirrhosis characterised by impaired contractile responsiveness to stress and/or altered diastolic relaxation with electrophysiological abnormalities in the absence of other known cardiac disease |
| Diagnostic criteria |
| Systolic dysfunction |
| Blunted increase in cardiac output with exercise, volume challenge or pharmacological stimuli |
| Resting EF < 55% |
| Diastolic dysfunction |
| E/A ratio < 1.0 (age-corrected) |
| Prolonged deceleration time (> 200 ms) |
| Prolonged isovolumetric relaxation time (> 80 ms) |
| Supportive criteria |
| Electrophysiological abnormalities |
| Abnormal chronotropic response |
| Electromechanical uncoupling/dyssynchrony |
| Prolonged Q-T interval |
| Enlarged left atrium |
| Increased myocardial mass |
| Increased BNP and pro-BNP |
| Increased troponin I |
- Citation: Møller S, Henriksen JH, Bendtsen F. Extrahepatic complications to cirrhosis and portal hypertension: Haemodynamic and homeostatic aspects. World J Gastroenterol 2014; 20(42): 15499-15517
- URL: https://www.wjgnet.com/1007-9327/full/v20/i42/15499.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i42.15499